| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,944,851 | 5,522,897 | 5,508,990 | 5,700,904 | | Cost of Revenue | 2,226,240 | 2,107,971 | 2,101,504 | 2,190,005 | | | Gross Profit | 3,718,611 | 3,414,926 | 3,407,486 | 3,510,899 | | | Operating Expenses | | Research Development | 757,524 | 707,626 | 641,643 | 733,341 | | Selling General and Administrative | 887,369 | 833,406 | 882,252 | 917,353 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,073,718 | 1,873,894 | 1,883,591 | 1,860,205 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (17,718) | 6,210 | (1,024,858) | | Earnings Before Interest And Taxes | 2,066,541 | 1,856,176 | 1,889,801 | 835,347 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,066,541 | 1,856,176 | 1,889,801 | 835,347 | | Income Tax Expense | 427,566 | 371,631 | 466,973 | 452,905 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,638,975 | 1,484,545 | 1,422,828 | 382,442 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,638,975 | 1,484,545 | 1,422,828 | 382,442 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,638,975 | $1,484,545 | $1,422,828 | $382,442 |
|
0.20% Nasdaq 
0.14%
Income Statement
